Co.'s Clinical Program in HPV+ Cancers Gives It a Buy Rating
Source: Dr. Joseph Pantginis  (9/23/22)
To fund continued development of its lead immunotherapy candidate, the U.S.-based biopharma recently completed a $35 million debt financing agreement, noted an H.C. Wainwright & Co. report. More >

Analyst Says Buy Before Biotech Co.'s Clinical Trials
Source: Dr. David Nierengarten  (9/23/22)
Argenx SE has "several upcoming catalysts," noted a Wedbush report. More >

Cobalt Refiner Signs 3-Yr. Supply Deal With EV Battery Maker
Source: Streetwise Reports  (9/23/22)
Shares of Electra Battery Materials Corp. traded 13% higher yesterday after the company reported it entered into a 3-year supply agreement with LG Energy Solution of South Korea to provide 7,000 tonnes of cobalt sulfate for use in manufacturing batteries for electric vehicles in North America. More >

Gold Co. 'Looking Like a Good Value'
Source: Clive Maund  (9/23/22)
With good news shown on Tuesday, Strikepoint Gold Inc. has piqued expert Clive Maund's interest. Today he reviews the gold company's 3-year and 6-month charts to tell you where he believes the stock is headed. More >

Junior Sells Yukon Projects To Focus on Golden Triangle
Source: Streetwise Reports  (9/22/22)
StrikePoint Gold Inc. is selling its Yukon Territory properties so it can better focus on its flagship Porter and Willoughby projects in the Golden Triangle. More >

Timing the US Market Crash: A Roadmap
Source: Clive Maund  (9/22/22)
Expert Clive Maund reviews the charts for the broad stock market to tell you when he believes the U.S. market will crash. More >

Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World
Source: Streetwise Reports  (9/21/22)
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc. More >

Expert Says Silver Co. Is a Buy up to CA$0.20
Source: Michael Ballanger  (9/21/22)
Expert Michael Ballanger reflects on his views of Norseman Silver last April to compare his opinion of the company then versus what he sees now. More >

FDA Approves Hearing Loss Drug for Child Chemo Patients
Source: Streetwise Reports  (9/21/22)
Shares of Fennec Pharmaceuticals Inc. traded 14% higher after the company reported it received approval from the U.S. FDA for its PEDMARK® (sodium thiosulfate injection) for use in reducing the risk of ototoxicity in pediatric patients who are undergoing or completed chemotherapy for non-metastatic solid tumors. More >

Dermatology Co.'s Target Price Much Higher Than Current
Source: Dr. Jonathan Aschoff  (9/20/22)
The biopharma's strategic marketing campaign "should continue growing U.S. sales to current and new customers," noted a ROTH Capital Partners report. More >

Important Catalyst Expected Soon for Cancer Drug Co.
Source: Dr. David Nierengarten  (9/20/22)
The biopharma should announce initial clinical trial data on its lead small molecule candidate by year-end, noted a Wedbush report. More >

Junior Continues Pivot With Nevada Lithium Project
Source: Streetwise Reports  (9/20/22)
Rover Metals Inc. is moving quickly as it eyes the all-important critical metals and minerals sector with a district-scale claystone lithium project in Nevada. More >

Biopharma Co.'s Shares Rise on Phase 3 Migraine Trial Data
Source: Streetwise Reports  (9/20/22)
Satsuma Pharmaceuticals Inc. shares traded 12% higher to a new 52-week high after the company reported positive results from its Phase 3 long-term study of STS101 for use in acute treatment of migraine attacks. The company expects to receive further efficacy data from its Phase 3 SUMMIT trial in Q4/22, which it believes will support submission of an NDA with the U.S. FDA in Q1/23. More >

Updates on These Three Mining Stocks
Source: Clive Maund  (9/19/22)
Expert Clive Maund takes a look at charts from Infinitum Copper Corp., Reyna Gold Corp., and Reyna Silver Corp. to tell you where he thinks these three mining stocks are going. More >

Mining Co. Reports More Good Drill Results in Spain
Source: Adam Schatzker  (9/19/22)
"It certainly appears that Romanera could prove to be a significant precious metals deposit," noted a Research Capital Corp. report. More >

Top-10 Producer Offers $150M for Nevada Gold Property
Source: Streetwise Reports  (9/19/22)
Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher. More >

Second Trial of New Eczema Drug To Commence in Q4/22
Source: Dr. Yi Chen  (9/17/22)
The purpose behind this complementary study is to potentially expand the treatment's target patient population, noted an H.C. Wainwright & Co. report. More >

Silver Explorer Expands Golden Triangle Drilling Campaign
Source: Streetwise Reports  (9/16/22)
Dolly Varden Silver Corp. is adding a fourth diamond drilling rig to its campaign at its Kitsault Valley project in British Columbia after seeing big returns. More >

Tech Co. Ready To Advance in a New Bull Market
Source: Clive Maund  (9/16/22)
Expert Clive Maund reviews Danavation Technologies Corp. after the completion of a large base pattern to see whether he believes it is a Buy. More >

Junior Closes on Deal for Critical Metals, Minerals Project
Source: Streetwise Reports  (9/16/22)
Copper and other critical metals and minerals are the backbone of the world's switch to green energy, and Rover Metals Corp. hopes to supply some of them. More >

FDA Grants Approval for Drug Improving Kidney Function
Source: Streetwise Reports  (9/16/22)
Shares of Mallinckrodt Plc. traded 28% higher yesterday after the company reported that the U.S. FDA has issued approval for its Terlivaz® (terlipressin) for injection for use in treating hepatorenal syndrome, a serious and life-threatening condition that is accompanied by rapid reduction in kidney function. More >

Bowling Center's Shares Score New 52-Week High
Source: Streetwise Reports  (9/16/22)
Shares of bowling center operator Bowlero Corp. traded 7.5% higher and rolled to a new 52-week high after the company reported Q4/22 and FY/22 financial results that included a 130.7% YoY increase in annual revenue. More >

Price Target on US Biopharma Co. Boosted by $15
Source: Julian Harrison  (9/15/22)
The increase came after positive clinical trial results on one of its lead drug candidates differentiating it from a competitor, noted a BTIG report. More >

New Drug Shown To Help Patients With Desmoid Tumors
Source: Dr. David Nierengarten  (9/15/22)
This oral gamma-secretase inhibitor met the primary and secondary endpoints in a Phase 3 clinical trial, noted a Wedbush report. More >

Three-Part Approach to Advancing Gold Project Gets Results
Source: Mike Niehuser   (9/15/22)
The explorer recently hit upon the main deposit's feeder zone, discovered a new vein nearby and keeps drilling high-grade gold intercepts, noted a ROTH Capital Partners report. More >